ATE235245T1 - Pharmaceutische komposition - Google Patents

Pharmaceutische komposition

Info

Publication number
ATE235245T1
ATE235245T1 AT96925883T AT96925883T ATE235245T1 AT E235245 T1 ATE235245 T1 AT E235245T1 AT 96925883 T AT96925883 T AT 96925883T AT 96925883 T AT96925883 T AT 96925883T AT E235245 T1 ATE235245 T1 AT E235245T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
wounds
mannose
healing
promoting
Prior art date
Application number
AT96925883T
Other languages
English (en)
Inventor
Mark William James Ferguson
Sally Freeman
Sarah Glenys Moore
Original Assignee
Renovo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Renovo Ltd filed Critical Renovo Ltd
Application granted granted Critical
Publication of ATE235245T1 publication Critical patent/ATE235245T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT96925883T 1995-08-04 1996-07-31 Pharmaceutische komposition ATE235245T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516012.3A GB9516012D0 (en) 1995-08-04 1995-08-04 Pharmaceutical composition
PCT/GB1996/001840 WO1997005883A1 (en) 1995-08-04 1996-07-31 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
ATE235245T1 true ATE235245T1 (de) 2003-04-15

Family

ID=10778773

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02079259T ATE298579T1 (de) 1995-08-04 1996-07-31 Phosphnatanaloge von mannose-6-phosphate und deren verwendung zur förderung der heilung von wunden oder fibrotischen störungen mit verminderter narbenbildung
AT96925883T ATE235245T1 (de) 1995-08-04 1996-07-31 Pharmaceutische komposition

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT02079259T ATE298579T1 (de) 1995-08-04 1996-07-31 Phosphnatanaloge von mannose-6-phosphate und deren verwendung zur förderung der heilung von wunden oder fibrotischen störungen mit verminderter narbenbildung

Country Status (13)

Country Link
US (1) US6140307A (de)
EP (2) EP0841931B1 (de)
JP (2) JPH11510179A (de)
AT (2) ATE298579T1 (de)
AU (1) AU719992B2 (de)
CA (1) CA2229010C (de)
DE (2) DE69626987T2 (de)
DK (2) DK1291018T3 (de)
ES (2) ES2243657T3 (de)
GB (1) GB9516012D0 (de)
PT (2) PT1291018E (de)
WO (1) WO1997005883A1 (de)
ZA (1) ZA966578B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2304047A (en) * 1995-08-09 1997-03-12 Univ Manchester Pharmaceutical compositions containing cytokines
US6093388A (en) * 1996-08-12 2000-07-25 Btg International Limited Mannose-6-phosphate composition and its use in treating fibrotic disorders
GB2316002B (en) * 1996-08-12 1998-09-23 British Tech Group Mannose-6-phosphate composition and its use in treating fibrotic disorders
AUPQ872300A0 (en) * 2000-07-11 2000-08-03 Praxis Pharmaceuticals Pty Ltd Compounds and methods
EP1628987B1 (de) * 2003-05-20 2009-08-19 Pharmaxis Pty Ltd. Mannose-6-phosphonat-verbindungen zur behandlung von entzündungskrankheiten
US20080057072A1 (en) * 2006-08-31 2008-03-06 Alcon Manufacturing, Ltd. Antagonists of ci-m6p/igf2r for prevention and treatment of ctgf-mediated ocular disorders
WO2008144352A1 (en) 2007-05-17 2008-11-27 Sunny Biodiscovery, Inc. Threitol phosphates, salts thereof and methods of use
GB0724231D0 (en) * 2007-12-12 2008-01-30 Renono Ltd Methods for inhibiting scarring
GB0910078D0 (en) 2009-06-11 2009-07-22 Renovo Ltd Uses of mannose-6-phosphate
GB0916334D0 (en) 2009-09-17 2009-10-28 Renovo Ltd Inhibition of tendon adhesions
GB0916332D0 (en) * 2009-09-17 2009-10-28 Renovo Ltd Medicaments
JP7521813B2 (ja) * 2018-08-10 2024-07-24 ニューヨーク ユニバーシティ 記憶力増強及び記憶障害軽減のためのマンノース６リン酸及びその修飾体の使用
JP7466927B2 (ja) 2018-08-10 2024-04-15 ニューヨーク ユニバーシティ アンジェルマン症候群及び自閉症を治療するためのｉｇｆ―２受容体作動剤リガンドの使用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4703040A (en) * 1985-04-03 1987-10-27 Markov Angel K Treatment of adult respiratory distress syndrome (ARDS) using fructose diphosphate (FDP)
DE68926746T2 (de) * 1988-08-19 1996-11-28 Univ Australian Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
SE8904354D0 (sv) * 1989-12-21 1989-12-21 Matti Siren A pharmaceutical composition
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
DK129293D0 (da) * 1993-11-16 1993-11-16 Carlsberg Lab Carbonhydratholdige forbindelser, der kan binde sig til carbonhydratbindende receptorer

Also Published As

Publication number Publication date
ZA966578B (en) 1998-02-02
JPH11510179A (ja) 1999-09-07
EP1291018A1 (de) 2003-03-12
EP1291018B1 (de) 2005-06-29
DK0841931T3 (da) 2003-04-22
HK1053264A1 (en) 2003-10-17
AU719992B2 (en) 2000-05-18
DE69626987T2 (de) 2003-12-04
AU6624896A (en) 1997-03-05
PT841931E (pt) 2003-06-30
GB9516012D0 (en) 1995-10-04
DE69634905T2 (de) 2006-04-27
EP0841931A1 (de) 1998-05-20
JP2008239625A (ja) 2008-10-09
PT1291018E (pt) 2005-08-31
DE69634905D1 (de) 2005-08-04
CA2229010A1 (en) 1997-02-20
ATE298579T1 (de) 2005-07-15
ES2243657T3 (es) 2005-12-01
ES2195000T3 (es) 2003-12-01
DE69626987D1 (de) 2003-04-30
WO1997005883A1 (en) 1997-02-20
US6140307A (en) 2000-10-31
EP0841931B1 (de) 2003-03-26
DK1291018T3 (da) 2005-09-12
CA2229010C (en) 2009-06-02

Similar Documents

Publication Publication Date Title
GB9516287D0 (en) Pharmaceutical compositon
FR2626760B1 (fr) Endoscope, notamment pour la chirurgie endonasale
PT877716E (pt) Composicoes de vidro bioactivo para uso no tratamento de estruturas dentais
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
EP1007556A4 (de) Troponin untereinheiten und fragmente zur verwendung als inhibitoren der angiogenese
ES2140670T3 (es) Cicatrizacion de heridas.
IS5591A (is) Grunnmassaprótínsamsetningar til sáragræðslu
ES2195000T3 (es) Composicion farmaceutica.
DE69633396D1 (de) Activin stimulator enthaltende pharmazeutische zusammensetzung
GB9516967D0 (en) Pharmaceutical composition
ITTO930024A0 (it) Composizione per accelerare la rimarginazione di ferite
GB9516073D0 (en) Pharmaceutical composition
AU1506692A (en) Pharmaceutical compositions
PT1115375E (pt) Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
PT661058E (pt) Utilizacao de antagonistas da bradiquinina para o tratamento de doencas virais
BR9704964A (pt) Uso de sulbutiamina para obter composições farmacêuticas úteis no tratamento de algumas pertubações psicomotoras e psico-intelectuais
BR9710992A (pt) Derivados anticovulsivos úteis no tratamento de psorìase
BR9812489A (pt) Uso de 6,7-substituìdas-2-aminotetralinas adequadas para a preparação de uma composição farmacêutica para o tratamento terapêutico de patologias inflamatórias e/ou autoimunes
IT8919204A0 (it) Composizione per la prevenzione e la cura di parodontopatte.
KR970702034A (ko) 과도한 산 분비와 관련된 경미한 위장관 질환의 치료를 위한 저용량 라니티딘 조성물(Low Dosage Ranitidine Compositions for the Treatment of Minor Gastrointestinal Disorders Associated with Excess Acid Secretion)
IT8419193A0 (it) Fortemente ioniche aventi azione compoisizioni farmaceutiche per la sulla mobilizzazione del calcio somministrazione orale di sostanze osseo.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0841931

Country of ref document: EP